Industry Partners

More effective drugs with fewer side effects rely on an ever better understanding of the molecular basis of health and disease.

An intensive dialog between academic research and the scientists at the pharmaceutical industry can thus hopefully contribute to progress in drug development. We are currently working on developing novel collaborative models with industry partners on select topics in drug discovery and development.

Both Hoffman-La Roche Inc. and Novartis Inc. have representatives in our executive and stratey boards.

We aim to further expand our connections with partners from the local pharmaceutical industry.

Hoffman-La Roche Inc.

Novartis Inc.